We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52103 679 3 CRSP
Emcee:  Biomaven Type:  Moderated
Biotech stocks are a close second only to internet stocks in how difficult they are to objectively value. This means that biotech stocks can be wildly under- or over-valued, which creates an opportunity for either profit or frustration for an investor that "knows better than market." To paraphrase the master: "Every now and again you should look at the stock price to see if the market is offering to do anything stupid."

This thread grew out of the "Munch-a-Biotech" thread, and is meant to discuss biotech stock valuation methods of all sorts, as well as particular stocks or sectors you may feel are under- or over-valued.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
52103here is a follow-up freakonomics podcast on how PE firms operate in general rathsoftware salesperson1November 28
52102Re: CRSP Trade History.................................. Since adding CRSP to mOldAIMGuy1November 20 novavax locator - - open appts. in your area in 2nd to last paragrasoftware salesperson1November 20
52100TENX up 295% CHAPEL HILL, N.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Tenax TherapeuAloner-November 13 The latest on a glp-1 drug: To me the biggest concern isoftware salesperson2November 12
52098eric topol's latest substack on nasal vaccines at: esoftware salesperson3October 15
52097Geez just a couple day bounce after my last post and now on to new lows. The CriJamesK-October 2 scroll up how to interpret free home rapid covid salesperson-September 27 Eric Topol analyzes: When the Breakthrough Obesity G-Agsoftware salesperson2September 27
52094Intercept gets $800m for the residual value of the company after a second Nash fA.J. Mullen-September 27
52093XBI at 52 week low. RSI near 20. Looking at prior biotech bears this may be abouJamesK1September 25
52092it turns out that it is not a new concept. too many diagrams to post link? - - software salesperson3September 17 new concept " inverse vaccine". A new type of vaccisoftware salesperson3September 16
52090data from James Webb Space Telescope causes rethinking of the assumptions of thsoftware salesperson1September 3
52089Not sure why you chose to compare NTLA to IONS when BBIO and ALNY seem better poJamesK-August 25
52088Regeneron is also working with Intellia (NTLA) on CRISPR technology to treat traArt Bechhoefer-August 24
52087I had missed this, a higher dose for Eylea, This was more imA.J. Mullen-August 21
52086The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Veopoz (poA.J. Mullen-August 21
52085Something is afoot. This thing is running like a scalded dog after have been beaFJV-August 14
52084Biotech continues to look sickly. Lot's of forced selling I would think froJamesK1August 9
52083Saw in AMGN earnings report that Repatha is now over $400 million in sales for tJamesK-August 9
52082CRDF up 25% After Hours SAN DIEGO, Aug. 7, 2023 /PRNewswire/ -- Cardiff OncologAloner-August 7
52081So of course they announce an offering: July 17, 2023 Amsterdam, the NetherlanAloner-July 17
52080ARGX up big today too. They have a multi billion dollar drug.JamesK-July 17
52079BBIO has a conference call on Monday for their ATTR drug. Some speculation on tJamesK-July 16
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):